RLMD
Relmada Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$5.91
-0.24 ▼ -3.90%
🌙 3월 13일 7:50 PM ET (한국 3/14 08:50)
$5.76
-0.15 ▼ -2.54%
| Index | - | P/E | - | EPS (ttm) | -1.8 | Insider Own | 17.52% | Shs Outstand | 0.07B | Perf Week | 32.81% |
| Market Cap | 0.43B | Forward P/E | - | EPS next Y | 43.68% | Insider Trans | 8.79% | Shs Float | 0.06B | Perf Month | 47.75% |
| Enterprise Value | 0.42B | PEG | - | EPS next Q | -0.15 | Inst Own | 66.09% | Short Float | 1.38% | Perf Quarter | 33.71% |
| Income | -0.06B | P/S | - | EPS this Y | 60.47% | Inst Trans | 40.51% | Short Ratio | 0.58 | Perf Half Y | 288.82% |
| Sales | 0.00B | P/B | 20.72 | EPS next 5Y | 31.68% | ROA | -159.13% | Short Interest | 0.84M | Perf YTD | 22.36% |
| Book/sh | 0.29 | P/C | 31.2 | EPS past 3/5Y | 28.2% 0.68% | ROE | -196.79% | 52W High | -21.3% ($7.51) | Perf Year | 2074.39% |
| Cash/sh | 0.19 | P/FCF | - | Sales past 3/5Y | - | ROIC | -593.46% | 52W Low | 2332.1% ($0.24) | Perf 3Y | 111.83% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 37.37% | Gross Margin | - | Volatility(W/M) | 13.92% 10.01% | Perf 5Y | -83.88% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.58 | Perf 10Y | 6.29% |
| Dividend Ex-Date | - | Quick Ratio | 2.86 | EPS Q/Q | 57.78% | Profit Margin | - | RSI (14) | 61.14 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.86 | Sales Q/Q | - | SMA20 | 21.53% ($4.86) | Beta | 0.61 | Target Price | $10.75 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 35.96% ($4.35) | Rel Volume | 0.88 | Prev Close | $6.15 |
| Employees | 17 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 29.28% - | SMA200 | 134.27% ($2.52) | Avg Volume(3M) | 1.44M | Price | $5.91 |
| IPO | 2014/6/20 | Option/Short | Yes/Yes | Trades | 10729 | Volume | 1,266,747 | Change | -3.9% |
뉴스 로딩 중...